Urotensin-II-stimulated expression of pro-angiogenic factors in human vascular endothelial cells

被引:23
作者
Albertin, Giovanna [1 ]
Guidolin, Diego [1 ]
Sorato, Elisa [1 ]
Oselladore, Barbara [1 ]
Tortorella, Cinzia [1 ]
Ribatti, Domenico [2 ]
机构
[1] Univ Padua, Sch Med, Dept Human Anat & Physiol, Sect Anat, I-65135121 Padua, Italy
[2] Univ Bari, Sch Med, Dept Human Anat & Histol, Bari, Italy
关键词
Angiogenesis; Human endothelial cells; Urotensin-II; Angiogenic factors; CORONARY-ARTERY-DISEASE; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; IN-VITRO; NITRIC-OXIDE; THERAPEUTIC TARGET; ORPHAN RECEPTOR; PROTEIN-KINASE; ADRENOMEDULLIN; RAT;
D O I
10.1016/j.regpep.2011.08.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Urotensin-II (U-II) is an endogenous peptide recently characterized as a "nonclassic" pro-angiogenic cytokine. In fact, human vascular endothelial cells express the U-II receptor and exhibit a strong in vitro angiogenic response to the peptide, which was specifically triggered by the binding of U-II to its receptor and involved the activation of ERK1/2 and PI3K/Akt signaling pathways. Moreover, available studies, designed to investigate the pro-angiogenic effect quite shortly following U-II stimulation, suggested that the angiogenic action of the peptide was direct and not associated with an increased expression of vascular endothelial growth factor (VEGF) and/or its receptors. In the present study, the expression of three pro-angiogenic factors, namely VEGF, endothelin-1, and adrenomedullin, was studied in human umbilical vein endothelial cells (HUVEC) for longer times of U-II stimulation. RT-PCR and Western blot indicated that in HUVEC, exposed for at least 24 h to U-II, the expression of the three angiogenic molecules was significantly increased at both mRNA and protein level, opening the possibility that U-II, not only could exert a direct stimulation of an angiogenic phenotype in endothelial cells quite shortly following exposure to the peptide, but could also further enhance the process indirectly by inducing in the cells a delayed production of other pro-angiogenic factors. Interestingly, a preliminary analysis of the time course of the in vitro capillary-like pattern formation was consistent with this view, suggesting a two phase temporal dynamics of the process. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 42 条
[1]  
Albertin G, 2005, INT J MOL MED, V15, P579
[2]  
Albertin G, 2005, INT J MOL MED, V16, P431
[3]   Involvement of vascular endothelial growth factor signaling in CLR/RAMP1 and CLR/RAMP2-mediated pro-angiogenic effect of intermedin on human vascular endothelial cells [J].
Albertin, Giovanna ;
Sorato, Elisa ;
Oselladore, Barbara ;
Mascarin, Alessandra ;
Tortorella, Cinzia ;
Guidolin, Diego .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 (02) :289-294
[4]   Pro-angiogenic activity of Urotensin-II on different human vascular endothelial cell populations [J].
Albertin, Giovanna ;
Guidolin, Diego ;
Sorato, Elisa ;
Spinazzi, Raffaella ;
Mascarin, Alessandra ;
Oselladore, Barbara ;
Montopoli, Monica ;
Antonello, Michele ;
Ribatti, Domenico .
REGULATORY PEPTIDES, 2009, 157 (1-3) :64-71
[5]   Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J].
Ames, RS ;
Sarau, HM ;
Chambers, JK ;
Willette, RN ;
Alyar, NV ;
Romanic, AM ;
Louden, CS ;
Foley, JJ ;
Sauermelch, CF ;
Coatney, RW ;
Ao, ZH ;
Disa, J ;
Holmes, SD ;
Stadel, JM ;
Martin, JD ;
Liu, WS ;
Glover, GI ;
Wilson, S ;
McNulty, DE ;
Ellis, CE ;
Elshourbagy, NA ;
Shabon, U ;
Trill, JJ ;
Hay, DWP ;
Ohlstein, EH ;
Bergsma, DJ ;
Douglas, SA .
NATURE, 1999, 401 (6750) :282-286
[6]   Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt):: First demonstration of a pathophysiological role of the urotensin system [J].
Clozel, M ;
Binkert, C ;
Birker-Robaczewska, M ;
Boukhadra, C ;
Ding, SS ;
Fischli, W ;
Hess, P ;
Mathys, B ;
Morrison, K ;
Müller, C ;
Müller, C ;
Nayler, O ;
Qiu, CB ;
Rey, M ;
Scherz, MW ;
Velker, J ;
Weller, T ;
Xi, JF ;
Ziltener, P .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (01) :204-212
[7]   In vitro culture of rat neuromicrovascular endothelial cells on polymeric scaffolds [J].
Conconi, MT ;
Lora, S ;
Baiguera, S ;
Boscolo, E ;
Folin, M ;
Scienza, R ;
Rebuffat, P ;
Parnigotto, PP ;
Nussdorfer, GG .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2004, 71A (04) :669-674
[8]   Urotensin II: fish neuropeptide catches orphan receptor [J].
Davenport, AP ;
Maguire, JJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (03) :80-82
[9]   Adrenomedullin as a therapeutic target in angiogenesis [J].
Deville, Jean-Laurent ;
Salas, Sebastien ;
Figarella-Branger, Dominique ;
Ouafik, L'Houcine ;
Daniel, Laurent .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (10) :1059-1072
[10]   Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease [J].
Douglas, SA ;
Ohlstein, EH .
TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (06) :229-237